[Cinarizine and Parkinson's disease. Double-blind placebo-controlled study].
Martí Massó
J F
JF
D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002936:Cinnarizine / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic
D002121:Calcium Channel Blockers; D002936:Cinnarizine; D007980:Levodopa
Cinaricina y enfermedad de Parkinson. Estudio doble ciego frente a placebo.